Emflaza Suspension
Product Images NDC 52856-505

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Emflaza (NDC 52856-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ptc Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Emflaza Is Deflazacort (a Corticosteroid).  corticosteroids Are Adrenocortical Steroids, Both Naturally Occurring And Synthetic.  the Molecular Formula For Deflazacort Is C25h31no6.  the Chemical Name For Deflazacort Is (11β,16β)-21-(acetyloxy)-11-hydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione. (Emflaza 01)

FDA Label Image

Figure A (Emflaza 02)

EMFLAZA™ is an oral suspension that comes with an oral dispenser. It may be used in households.*

FDA Label Image

Figure B (Emflaza 03)

FDA Label Image

Figure C (Emflaza 04)

FDA Label Image

Figure D (Emflaza 05)

FDA Label Image

Figure E (Emflaza 06)

FDA Label Image

Figure F (Emflaza 07)

FDA Label Image

Figure G (Emflaza 08)

FDA Label Image

Figure H (Emflaza 09)

FDA Label Image

Figure I (Emflaza 10)

FDA Label Image

Figure J (Emflaza 11)

FDA Label Image

Figure K (Emflaza 12)

FDA Label Image

Figure L (Emflaza 13)

FDA Label Image

6 mg Tablet 100-count Bottle Label (Emflaza 14)

This is a description of Emflaza® tablets, which come in a bottle with NDC number 52856-501-01 and contains 100 tablets. Each tablet contains 6 mg deflazacort, and the recommended dosage and administration should be consulted in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F). Emflaza® is a registered trademark of PTC Therapeutics, Inc. The text does not include the expiry date or lot number, so it is not-available.*

FDA Label Image

6 mg Tablet 100-count Carton Label (Emflaza 15)

This is a description of a medication called EMFLAZA® manufactured by PTC Therapeutics, Inc. The medication comes in 100 tablet form for oral use and its NDC is 52856-501-01. The tablets contain deflazacorteassnprnRaintanate. Dosage and administration information should be found in the package insert included with the tablets. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). EMFLAZA® is a registered trademark of PTC Therapeutics, Inc.*

FDA Label Image

18 mg Tablet 30-count Bottle Label (Emflaza 16)

This is a medication called Emflaza containing the active ingredient deflazacort, with NDC number 52856-502-03. Each bottle of this medication contains 30 tablets. There is no dosage and administration information provided in this text, and the reader is advised to consult the package insert for this information. This medication should be stored at a temperature between 20°C to 25°C. Emflaza is a registered trademark of PTC Therapeutics, Inc.*

FDA Label Image

18 mg Tablet 30-count Carton Label (Emflaza 17)

This appears to be information concerning a medication, likely called Emflaza, a registered trademark of PTq. Each tablet contains deflazacort. The dosage and administration details are not available but can be found in the package insert. The medication comes in 30 tablets, and should be stored at 20°C to 25°C (68°F to 77°F). It is for oral use and is manufactured for PTC Therapeutics, Inc. in South Plainfield, NJ 07080 U.S.A.*

FDA Label Image

30 mg Tablet 30-count Bottle Label (Emflaza 18)

This is a medication label for NDC 52856-503-03 containing 30 tablets of Deflazacort, each tablet containing 30 mg of Deflazacort. Dosage and administration information is available in the package insert. Store the medication at a temperature between 20°C to 25°C (68°F to 77°F). EMFLAZA® is a registered trademark of PTC Therapeutics, Inc. The lot number and expiration date are present but not readable in the text.*

FDA Label Image

30 mg Tablet 30-count Carton Label (Emflaza 19)

The text is providing information about a medication called Emflaza. The medication is available in tablet form for oral use and each tablet contains deflazacort. The dosage and administration information can be found in the package insert. The medication is manufactured by PTC Therapeutics and should be stored at controlled room temperature between 20°C to 25°C. The text also mentions the trademark for Emflaza.*

FDA Label Image

36 mg Tablet 30-count Bottle Label (Emflaza 20)

This is a description of a medication whose NDC code is 52856-504-03. It is a bottle of 30 tablets of deflazacort, an oral tablet medication which contains 36mg of deflazacort in each tablet. The dosage and administration information can be found in the package insert provided along. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The trademark of this medication is EMFLAZA® and it is registered to PTC Therapeutics, Inc. The lot number is given but the expiration date is not.*

FDA Label Image

36 mg Tablet 30-count Carton Label (Emflaza 21)

EMFLAZA® tablets are for oral use and each tablet contains 36mg of deflazacort. They are provided in a package with 30 tablets, and the recommended dosage and administration instructions are available in the package insert. The tablets should be stored between 20°C to 25°C (68°F to 77°F) and the USP Controlled Room Temperature guidelines should be followed. EMFLAZA® is a registered trademark of PTC Therapeutics, Inc. The product is manufactured by PTC Therapeutics, Inc. located in South Plainfield, NJ 07080, U.S.A. The product is identified using the NDC 52856-504-03 code.*

FDA Label Image

22.75 mg/ml Oral Suspension 13 mL Bottle Label (Emflaza 22)

FDA Label Image

22.75 mg/ml Oral Suspension 13 mL Carton Label (Emflaza 23)

This is a medication called Emflaza, which contains deflazacort. It comes in a press-in bottle adapter for oral suspension administration only. The dosage and administration instructions are included in the package insert. Each mL contains 22.75 mg/m I of deflazacort. The medication should be stored at 20°C to 25°C (68°F to 77°F), and the bottle should be tightly closed after opening. It is manufactured by PTC Therapeutics, Inc. in Spain and is a registered trademark of PTC Therapeutics, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.